--- title: "Capricor Therapeutics Inc. Metrics Guide" description: "Capricor Therapeutics Inc. revenue, margins, cash flow and balance sheet figures by fiscal year, taken from its SEC filings, with the ratios explained." canonical: https://www.getswoopr.com/stocks/companies/capricor-therapeutics-inc/financial-metrics/ source: "Swoopr Investment: https://www.getswoopr.com" --- # Capricor Therapeutics Inc. Financial Metrics Guide ## Direct Answer > Capricor Therapeutics Inc. reported revenue of $0 for the fiscal year ended December 31, 2025, net income of -$105 million, according to its SEC filings. Revenue fell 100.0% from the prior year. ## What Are Capricor Therapeutics Inc.'s Key Financial Figures? | Fiscal year | FY2025ended December 31, 2025 | FY2024ended December 31, 2024 | FY2023ended December 31, 2023 | FY2022ended December 31, 2022 | | --- | --- | --- | --- | --- | | Revenue | $0 | $22 million | $25 million | $3 million | | Operating income | -$108 million | -$43 million | -$24 million | -$30 million | | Operating margin | n/a | -191.1% | -95.6% | -1163.9% | | Net income | -$105 million | -$40 million | -$22 million | -$29 million | | Net margin | n/a | -181.7% | -88.5% | -1137.4% | | Operating cash flow | -$70 million | -$40 million | -$26 million | $5 million | | Capital expenditures | $3 million | $1 million | $1 million | $2 million | | Free cash flow | -$73 million | -$41 million | -$27 million | $3 million | Free cash flow (operating cash flow minus capital expenditures) was -$73 million against net income of -$105 million; cash generation covered reported earnings. ![Bar chart of Capricor Therapeutics Inc. revenue, operating income, net income for fiscal 2022 to 2025. In fiscal 2025, revenue was $0, operating income negative $108 million and net income negative $105 million.](https://www.getswoopr.com/images/charts/capricor-therapeutics-inc-metrics-revenue-profit.webp) *Capricor Therapeutics Inc. revenue, operating income and net income by fiscal year, from the figures in the table above. Select the chart to open it full size.* ![Line chart of Capricor Therapeutics Inc. operating margin and net margin for fiscal 2022 to 2025. In fiscal 2025, operating margin was n/a and net margin was n/a.](https://www.getswoopr.com/images/charts/capricor-therapeutics-inc-metrics-margins.webp) *Capricor Therapeutics Inc. operating margin and net margin by fiscal year: operating income and net income as a share of revenue. Select the chart to open it full size.* ![Bar chart of Capricor Therapeutics Inc. operating cash flow, capital expenditures, free cash flow for fiscal 2022 to 2025. In fiscal 2025, operating cash flow was negative $70 million, capital expenditures was $3 million, free cash flow was negative $73 million.](https://www.getswoopr.com/images/charts/capricor-therapeutics-inc-metrics-cash-flow.webp) *Capricor Therapeutics Inc. operating cash flow, capital expenditures and free cash flow by fiscal year. Select the chart to open it full size.* ## What Does Capricor Therapeutics Inc.'s Balance Sheet Show? | Cash and cash equivalents | $288 million | | --- | --- | | Long-term debt | Not reported | | Total assets | $356 million | | Total liabilities | $50 million | | Shareholders' equity | $306 million | | Current ratio | 9.0x | Balance sheet values are as of the end of fiscal 2025. Income statement figures describe a whole year; balance sheet figures describe a single day, so the two answer different questions. ## Where These Numbers Come From Every figure on this page is a value Capricor Therapeutics Inc. reported in its own SEC filings, read from the SEC's XBRL data (accession 0001104659-26-029580 for fiscal year 2025). Ratios are computed from those reported values. Figures were retrieved on October 7, 2026; a later amendment or a new annual report can change them, and the filing itself always takes precedence over this summary. Each fiscal year is labeled by the calendar year in which it ended, so a company that names the same period differently in its own filings (many retailers whose year ends in January) may use another label. A year is left out of the table when the SEC data set holds no value for it. A figure shown as "Not reported" means the company did not file a value under the standard tag Swoopr reads, not that the amount was zero. This page is educational and describes reported history only; it is not a forecast or a recommendation. ## Frequently Asked Questions ### What was Capricor Therapeutics Inc.'s revenue in fiscal 2025? Capricor Therapeutics Inc. reported revenue of $0 for the fiscal year ended December 31, 2025, according to its SEC filings. ### What is Capricor Therapeutics Inc.'s operating margin? Capricor Therapeutics Inc. did not report operating income under the standard tag for fiscal 2025, so Swoopr does not compute an operating margin; the income statement in its 10-K shows how it presents profit. ### How much free cash flow did Capricor Therapeutics Inc. generate? Operating cash flow of -$70 million less capital expenditures of $3 million gives free cash flow of -$73 million for fiscal 2025. ## References - [SEC EDGAR: CAPRICOR THERAPEUTICS, INC. Form 10-K filed March 17, 2026](https://www.sec.gov/Archives/edgar/data/1133869/000110465926029580/capr-20251231x10k.htm) - [SEC EDGAR: CAPRICOR THERAPEUTICS, INC. annual and quarterly filings](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1133869&type=10-K) - [SEC: EDGAR application programming interfaces (XBRL frames and submissions data)](https://www.sec.gov/search-filings/edgar-application-programming-interfaces) ## Related Pages - [Capricor Therapeutics Inc. company dossier](https://www.getswoopr.com/stocks/companies/capricor-therapeutics-inc/) - [Capricor Therapeutics Inc. financial metrics](https://www.getswoopr.com/stocks/companies/capricor-therapeutics-inc/financial-metrics/) - [Capricor Therapeutics Inc. financial risk indicators](https://www.getswoopr.com/stocks/companies/capricor-therapeutics-inc/risks-monitoring/) - [Capricor Therapeutics Inc. business model and revenue mix](https://www.getswoopr.com/stocks/companies/capricor-therapeutics-inc/business-model/) - [Fundamental analysis guides](https://www.getswoopr.com/learn/fundamental-analysis/) [Swoopr Editorial Team](https://www.getswoopr.com/authors/swoopr-editorial-team/) Swoopr's editorial team produces independent investment education content. Content is for educational purposes only and does not constitute personalized investment advice. See our [editorial policy](https://www.getswoopr.com/legal/editorial-policy/) and [corrections policy](https://www.getswoopr.com/legal/corrections-policy/).